Weekly updateCompaniesPost a job
Obsidian Therapeutics

Obsidian Therapeutics

    Company info:

  • 51-100
  • 2015
  • Cambridge, MA
  • 100-500M



Claim company profile

About company:

Obsidian Therapeutics is developing tumor infiltrating lymphocyte (TIL) therapies for patients with intractable diseases. Conventional TIL therapies have had some success for cancer patients but are still limited by toxicity concerns caused by concomitant IL2 therapy. Using their proprietary cytoDRIVE platform, Obsidian is engineering cytoTIL therapies to express therapeutic proteins that enhance anti-tumor activity and reduce toxicity. Obsidian’s lead program, cytoTIL15, has been engineered to eliminate the need for concomitant IL2 therapy improving the magnitude and duration of response. cytoTIL15 will enter clinical trials for patients with metastatic melanoma.


Obsidian Therapeutics
Executive Assistant (C-Suite)
Cambridge, MA|5 days ago
Obsidian Therapeutics
Associate Director, Supply Chain and Logistics
Cambridge, MA|39 days ago
Obsidian Therapeutics
Director, GMP Quality
Cambridge, MA|88 days ago
Obsidian Therapeutics
Principal Scientist, Analytical Development
Cambridge, MA|96 days ago
Obsidian Therapeutics
General Interest Application - Obsidian Talent Com...
Cambridge, MA|100+ days ago

© 2022 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com